Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	973.7	854	472.3	648.03	445.64	71.82
Short-Term Investments	3,031	-	-	-	-	-
Trading Asset Securities	-	1,917	7,739	4,189	4,812	1,806
Cash & Short-Term Investments	4,005	2,771	8,211	4,837	5,258	1,878
Cash Growth	-38.94%	-66.25%	69.75%	-8.00%	180.01%	343.20%
Accounts Receivable	5,897	2,844	1,337	1,109	2,364	1,024
Other Receivables	159.6	885.1	562.3	665.92	480.04	516.22
Receivables	6,194	3,733	1,907	1,777	2,846	1,542
Inventory	5,929	1,729	2,332	3,306	3,000	2,127
Prepaid Expenses	-	104.4	49.2	86.28	64	43.97
Other Current Assets	2,324	547.3	32.7	103.79	111.67	56.72
Total Current Assets	18,452	8,886	12,532	10,110	11,279	5,648
Property, Plant & Equipment	21,199	12,500	7,868	7,662	5,620	5,349
Long-Term Investments	1,510	1,450	1,306	1,171	1,171	3,612
Goodwill	12,548	6,551	602.5	602.58	-	-
Other Intangible Assets	986.2	638.9	16.8	19.32	22.36	25.91
Long-Term Deferred Tax Assets	5.5	5.5	8.1	-	-	-
Other Long-Term Assets	975.1	240.8	216	91.64	203.02	109.54
Total Assets	55,685	30,318	22,549	19,657	18,296	14,745
Accounts Payable	3,133	802.1	423.5	700.92	1,059	829.31
Accrued Expenses	415.6	1,415	256.9	128.17	266	198.03
Short-Term Debt	-	700	385.8	445.98	-	641.89
Current Portion of Long-Term Debt	1,487	18.9	-	200	671.33	414.48
Current Portion of Leases	236.1	314.5	51.9	4.79	10.91	10.68
Current Income Taxes Payable	73.3	11	-	2.94	36.42	-
Current Unearned Revenue	-	21.6	6.9	8.08	-	-
Other Current Liabilities	969.4	369.3	49	96.79	59.27	103.08
Total Current Liabilities	6,314	3,652	1,174	1,588	2,103	2,197
Long-Term Debt	728.6	62.4	-	45.64	284.4	355.91
Long-Term Leases	2,056	1,695	212.4	7	4.63	7.39
Pension & Post-Retirement Benefits	2.6	2.6	-	-	11.09	21.57
Long-Term Deferred Tax Liabilities	777.3	909.8	656	582.35	543.15	309.33
Other Long-Term Liabilities	6,560	5,590	-	82.95	77.85	44.99
Total Liabilities	16,439	11,911	2,042	2,306	3,024	2,937
Common Stock	382.6	254.6	254.6	254.57	254.57	254.57
Additional Paid-In Capital	-	1,096	1,096	1,096	1,096	1,096
Retained Earnings	-	15,083	18,894	15,894	13,820	10,308
Comprehensive Income & Other	37,495	532.8	262.3	107.17	101.65	150.09
Total Common Equity	37,877	16,966	20,507	17,352	15,272	11,808
Minority Interest	1,369	1,441	-	-	-	-
Shareholders' Equity	39,246	18,406	20,507	17,352	15,272	11,808
Total Liabilities & Equity	55,685	30,318	22,549	19,657	18,296	14,745
Total Debt	4,508	2,791	650.1	703.41	971.27	1,430
Net Cash (Debt)	-502.7	-19.3	7,561	4,134	4,287	447.4
Net Cash Growth	-	-	82.90%	-3.56%	858.10%	-
Net Cash Per Share	-1.96	-0.08	29.70	16.24	16.84	1.76
Filing Date Shares Outstanding	381.86	382.57	254.56	254.56	254.56	254.56
Total Common Shares Outstanding	381.86	254.56	254.56	254.56	254.56	254.56
Working Capital	12,139	5,234	11,358	8,523	9,176	3,450
Book Value Per Share	99.19	66.65	80.56	68.16	59.99	46.39
Tangible Book Value	24,343	9,776	19,887	16,730	15,249	11,782
Tangible Book Value Per Share	63.75	38.40	78.12	65.72	59.90	46.28
Land	-	307.8	150.5	150.46	150.46	150.46
Buildings	-	2,341	2,206	2,200	1,813	1,411
Machinery	-	8,108	5,797	5,410	4,750	3,909
Construction In Progress	-	2,548	1,790	1,651	299.94	961.49
Leasehold Improvements	-	117.7	42.6	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.